Emergent Biosolutions
EBS
EBS
168 hedge funds and large institutions have $717M invested in Emergent Biosolutions in 2014 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 57 increasing their positions, 50 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
9.04% more ownership
Funds ownership: 69.27% → 78.3% (+9%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
168
Holding in Top 10
1
Calls
$319K
Puts
–
Top Buyers
| 1 | +$18.5M | |
| 2 | +$10.7M | |
| 3 | +$10.7M | |
| 4 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
+$10.5M |
| 5 |
GAM
Gotham Asset Management
New York
|
+$6.54M |
Top Sellers
| 1 | -$25.1M | |
| 2 | -$12.9M | |
| 3 | -$7.31M | |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$4.75M |
| 5 |
AI
Ariel Investments
Chicago,
Illinois
|
-$2.82M |